CQENS Technologies Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223040452 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $350.6K $905.3K $933.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $43.89K $102.3K $307.9K
Receivables
Other Receivables
Total Short-Term Assets $394.5K $1.008M $1.242M
YoY Change -2.0% -18.84%
LONG-TERM ASSETS
Property, Plant & Equipment $157.6K $162.6K $182.8K
YoY Change -11.34% -11.02%
Goodwill
YoY Change
Intangibles $1.144M $1.123M $892.2K
YoY Change 17.48% 25.88%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.888M $1.848M $1.831M
YoY Change 7.85% 0.92%
TOTAL ASSETS
Total Short-Term Assets $394.5K $1.008M $1.242M
Total Long-Term Assets $1.888M $1.848M $1.831M
Total Assets $2.283M $2.856M $3.073M
YoY Change 6.01% -7.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $104.2K $135.3K $114.9K
YoY Change -53.19% 17.8%
Accrued Expenses $248.4K $280.7K $144.5K
YoY Change 164.16% 94.21%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.316M $1.375M $310.9K
YoY Change 256.88% 342.1%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.316M $1.375M $310.9K
Total Long-Term Liabilities
Total Liabilities $1.337M $1.410M $398.2K
YoY Change 201.85% 254.09%
SHAREHOLDERS EQUITY
Retained Earnings -$23.86M -$22.85M -$16.64M
YoY Change 22.0% 37.29%
Common Stock $2.618K $2.616K $2.606K
YoY Change 0.42% 0.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $946.0K $1.446M $2.675M
YoY Change
Total Liabilities & Shareholders Equity $2.283M $2.856M $3.073M
YoY Change 6.01% -7.07%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001479915
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 CQENS Related Party Loan
RelatedPartyLoan
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CQENS Increase Decrease In Prepaid Expenses Noncurrent Portion
IncreaseDecreaseInPrepaidExpensesNoncurrentPortion
usd
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CQENS Rightof Use Asset In Exchange For Lease Liability
RightofUseAssetInExchangeForLeaseLiability
usd
CY2023Q3 CQENS Lessee Operating Lease Liability Payments Due After Year Two
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55470
dei Entity Registrant Name
EntityRegistrantName
CQENS Technologies Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1521407
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
dei Entity Address Address Line1
EntityAddressAddressLine1
5550 Nicollet Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55419
dei City Area Code
CityAreaCode
(612)
dei Local Phone Number
LocalPhoneNumber
812-2037
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26166595 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
905325 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
219781 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
102251 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
182713 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1007576 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
402494 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
162611 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
177722 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1123095 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
973823 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
94152 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
126235 usd
CY2023Q3 CQENS Leasehold Improvements Net
LeaseholdImprovementsNet
9937 usd
CY2022Q4 CQENS Leasehold Improvements Net
LeaseholdImprovementsNet
14644 usd
CY2023Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
458317 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
458317 usd
CY2023Q3 us-gaap Assets
Assets
2855688 usd
CY2022Q4 us-gaap Assets
Assets
2153235 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
135307 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
222539 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
280656 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94050 usd
CY2023Q3 CQENS Related Party Loan
RelatedPartyLoan
900000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58553 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52217 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1374516 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
368806 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35599 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74018 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1410115 usd
CY2022Q4 us-gaap Liabilities
Liabilities
442824 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26161595 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26161595 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26065595 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26065595 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2616 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2607 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24291094 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21261500 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22848137 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19553696 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1445573 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1710411 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2855688 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2153235 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
339595 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
433299 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1385503 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2066156 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216840 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
255643 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
847335 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
572593 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
454940 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
266719 usd
us-gaap Professional Fees
ProfessionalFees
1053498 usd
us-gaap Professional Fees
ProfessionalFees
694149 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1011375 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
955661 usd
us-gaap Operating Expenses
OperatingExpenses
3286336 usd
us-gaap Operating Expenses
OperatingExpenses
3332898 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1237 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8105 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1012612 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-955672 usd
us-gaap Net Income Loss
NetIncomeLoss
-3294441 usd
us-gaap Net Income Loss
NetIncomeLoss
-3332909 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26133658 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26133658 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26055704 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26055704 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26093475 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26093475 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26029111 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26029111 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
750604 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1345000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
362581 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1012612 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1445573 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1710411 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1920000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1109603 usd
us-gaap Net Income Loss
NetIncomeLoss
-3294441 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1445573 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3085563 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
350000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
94726 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-955672 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2674617 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4430586 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
350000.00 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000.00 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1126940 usd
us-gaap Net Income Loss
NetIncomeLoss
-3332909 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2674617 usd
us-gaap Net Income Loss
NetIncomeLoss
-3294441 usd
us-gaap Net Income Loss
NetIncomeLoss
-3332909 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
74354 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
54327 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
32083 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
21388 usd
us-gaap Depreciation
Depreciation
15111 usd
us-gaap Depreciation
Depreciation
15046 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1109603 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1126940 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-80462 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
164528 usd
CQENS Increase Decrease In Prepaid Expenses Noncurrent Portion
IncreaseDecreaseInPrepaidExpensesNoncurrentPortion
601288 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-87232 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
32735 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-32083 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21388 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
186606 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
27710 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1915537 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2741967 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
218919 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
236944 usd
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
7800 usd
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
18044 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-218919 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-262788 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1920000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
350000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
900000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2820000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
350000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
685544 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2654755 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219781 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3588377 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
905325 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
933622 usd
CQENS Rightof Use Asset In Exchange For Lease Liability
RightofUseAssetInExchangeForLeaseLiability
160255 usd
CY2023Q2 CQENS Lease Monthly Installments
LeaseMonthlyInstallments
5175 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
62100 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
7500 shares
CY2023Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
150000 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1500 shares
CY2023Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
30000 usd
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
9750 shares
CY2023Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
195000 usd
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
10000 shares
CY2023Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
200000 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
25000 shares
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
500000 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
16000 shares
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
320000 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5000 shares
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
100000 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1250 shares
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
25000 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
20000 shares
CY2023Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
400000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1109603 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1126940 usd
CY2022Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
35000 shares
CY2022Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
350000 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26161595 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26161595 shares
CY2023Q2 CQENS Increase In Rent
IncreaseInRent
375 usd
CY2023Q3 CQENS Leasehold Improvements Net
LeaseholdImprovementsNet
9937 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
94152 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58553 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35599 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
32083 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
15525 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
62100 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20700 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
98325 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4173 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
94152 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
58553 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
35599 usd
us-gaap Manufacturing Costs
ManufacturingCosts
458317 usd
CY2023Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
458317 usd

Files In Submission

Name View Source Status
cqens-20230930_cal.xml Edgar Link unprocessable
cqens-20230930_def.xml Edgar Link unprocessable
0001493152-23-040452-index-headers.html Edgar Link pending
0001493152-23-040452-index.html Edgar Link pending
0001493152-23-040452.txt Edgar Link pending
0001493152-23-040452-xbrl.zip Edgar Link pending
cqens-20230930.xsd Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cqens-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
cqens-20230930_lab.xml Edgar Link unprocessable